Deleted Tweets From Scott Gottlieb, R-D.C.
Scott Gottlieb's accounts: SteveFDA
Tracked Between: October 20, 2017-January 20, 2021
SteveFDA (R-D.C.)
@SGottliebFDA
RT @US_FDA: Benefit-risk assessment is at the heart of what we do to ensure medical products are safe, effective, and meet pati… https://t.co/JhIhTSJlc8
SteveFDA (R-D.C.)
@SGottliebFDA
RT @FDAcdrhIndustry: Press Release: FDA authorizes first fully interoperable continuous glucose monitoring system, streamlines review pa… https://t.co/LzLgyfqqcY
SteveFDA (R-D.C.)
@SGottliebFDA
Chag Sameach https://t.co/UKN48WMwo1
SteveFDA (R-D.C.)
@SGottliebFDA
RT @drJoshS: If you are interested in food policy & #equity, worth reading @SGottliebFDA on the nutrition priorities of @US_FDA… https://t.co/7CR3iEOdoO
SteveFDA (R-D.C.)
@SGottliebFDA
RT @PMelmeyer: Big news today from #FDA: Even more efforts to integrate the patient voice into #RareDisease drug review! https://t.co/Jb5Qe… QT @SGottliebFDA: #FDA released today a new policy document related to our benefit-risk framework for assessing new drugs; detailing… https://t.co/0LEpPRYARA)
SteveFDA (R-D.C.)
@SGottliebFDA
RT @US_FDA: We continue to work in partnership w/ patients and look for more ways to incorporate their experience into our bene… https://t.co/gTXgKxUbF8
SteveFDA (R-D.C.)
@SGottliebFDA
RT @FDA_Track: Benefit-Risk Framework: #PDUFAVI Goals Outlined https://t.co/Tazb4ifslv #FDA #Drug
SteveFDA (R-D.C.)
@SGottliebFDA
RT @FDA_Track: Statement from FDA Commissioner Scott Gottlieb, M.D., on FDA’s efforts to enhance the #patient perspective and expe… https://t.co/ICBm7HIQoe
SteveFDA (R-D.C.)
@SGottliebFDA
RT @SGottliebFDA: #FDA released today a new policy document related to our benefit-risk framework for assessing new drugs; detailing… https://t.co/0LEpPRYARA
SteveFDA (R-D.C.)
@SGottliebFDA
Benefit-risk assessment is at heart of what we do at #FDA to ensure medical products are safe, effective, meet patient needs. We issued a new Benefit-Risk Assessment in Drug Regulatory Decision-Making, to build in the patient perspective to our decisions
SteveFDA (R-D.C.)
@SGottliebFDA
The #FDA’s new nutrition strategy aims to leverage the tools of diet and nutrition as a way to better address the burden of chronic disease, troubling disparities when it comes to diet, and inequality in health and medical outcomes https://t.co/vv1KrJ4L5l
SteveFDA (R-D.C.)
@SGottliebFDA
Pan American Health Organization warns in face of ongoing measles outbreaks in Americas; countries should redouble efforts to vaccinate. Seeing outbreaks in South America & U.S. is an avoidable tragedy. #VaccinesWork. Resurgence of measles is devastat
SteveFDA (R-D.C.)
@SGottliebFDA
#FDA’s new “Nutrition Innovation Strategy” aims to instigate healthful food innovation that can help reduce the burden of chronic disease; close dietary disparities that also contribute to health inequality. Read the plan here: https://t.co/U2LGZWRHjM ht
SteveFDA (R-D.C.)
@SGottliebFDA
Last week, I laid out #FDA's new plan to leverage nutrition as a tool to reduce chronic disease. Among other things, we commit to define label terms in new regs. Today's WSJ Edit Page calls on us to do the same. For those who missed the plan, here's it is
SteveFDA (R-D.C.)
@SGottliebFDA
RT @megtirrell: Takeaways from our interview with @SGottliebFDA at #HealthyReturns last week https://t.co/UKhSf7jvqJ QT @SGottliebFDA: https://t.co/0YKmV1rScT)
SteveFDA (R-D.C.)
@SGottliebFDA
#FDA's new, updated benefit-risk plan improves the clarity and consistency of how the agency communicates the reasoning behind drug regulatory decisions; and provides a better framework for incorporating patient perspective into drug development and revie
SteveFDA (R-D.C.)
@SGottliebFDA
RT @HHSMedia: HHS @SecAzar: Our commitment to fighting the #opioid crisis https://t.co/GyHSMg1dtQ via @UnionLeader
SteveFDA (R-D.C.)
@SGottliebFDA
RT @CDCDirector: Overall, H3N2 flu viruses have predominated this season, but #FluView shows influenza B viruses have been more comm… https://t.co/lKV4OoGYBX
SteveFDA (R-D.C.)
@SGottliebFDA
RT @SeemaCMS: .@CMSGov has finalized policies for #Medicare health & drug plans in 2019 that’ll save beneficiaries money on presc… https://t.co/2m1eh760d3